European Personalised Medicine Diagnostics Association November 15, 2009

We all know about the Personalised Medicine Coalition:

The Personalized Medicine Coalition (PMC) is an independent, non-profit group that works to advance the understanding and adoption of personalized medicine for the ultimate benefit of patients. Our diverse members work together to educate opinion leaders and the public about the issues that will shape how personalized medicine develops — and how quickly all of us can benefit from it.

Now I was glad to see the European Personalised Medicine Diagnostics Association just launched as reported by GenomeWeb.

Made up of biotechnology firms, academic and institutional researchers, small and large businesses, and patient advocacy groups, the European Personalised Medicine Diagnostics Association (EPEMED) announced its board of directors this week. Included on that board are executives from Ipsogen, Genzyme Genetics, Oncomethylome Sciences, the Personalized Medicine Coalition, BioMerieux, Theranostics, and Novartis Molecular Diagnostics.

EPEMED says its central goals are to move personalized medicine forward throughout Europe through targeted education, idea-sharing, and business models, and to promote harmonization in Europe’s approach to personalized medicine.